As Harpreet alluded to, we have seven APAs. I think six of them have received regulatory approval. We had an opportunity to purchase up to 412 million doses. Some of those are firm, and some of those are options that are triggered at the request of Canada. We continue to work with all of the suppliers to adjust the supply based on demand.
On February 6th, 2023. See this statement in context.